Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway
出版年份 2019 全文链接
标题
Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway
作者
关键词
Rutin, Carfilzomib, Nephrotoxicity, NOS-2, NF-κB, Histopathology
出版物
INFLAMMOPHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-01-01
DOI
10.1007/s10787-018-0550-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms involved in the possible nephroprotective effect of rutin and low dose γ irradiation against cisplatin-induced nephropathy in rats
- (2017) Rasha R. Radwan et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Dexamethasone Attenuates LPS-induced Acute Lung Injury through Inhibition of NF-κB, COX-2, and Pro-inflammatory Mediators
- (2016) Naif O. Al-Harbi et al. IMMUNOLOGICAL INVESTIGATIONS
- Rutin ameliorates kidney interstitial fibrosis in rats with obstructive nephropathy
- (2016) Bin Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Rutin Prevents High Glucose-Induced Renal Glomerular Endothelial Hyperpermeability by Inhibiting the ROS/Rhoa/ROCK Signaling Pathway
- (2016) Xiaoming Wang et al. PLANTA MEDICA
- Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats
- (2016) Faisal Imam et al. TOXICOLOGY MECHANISMS AND METHODS
- Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats
- (2016) Naif O. Al-Harbi TOXICOLOGY MECHANISMS AND METHODS
- Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats
- (2016) Faisal Imam et al. TOXICOLOGY MECHANISMS AND METHODS
- Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats
- (2016) Naif O. Al-Harbi TOXICOLOGY MECHANISMS AND METHODS
- Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress
- (2015) Faisal Imam et al. Cardiovascular Toxicology
- Selenium and rutin alone or in combination do not have stronger protective effects than their separate effects against cadmium-induced renal damage
- (2015) Sunny O. Abarikwu et al. PHARMACEUTICAL BIOLOGY
- Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity
- (2015) Blanca Humanes et al. Biomed Research International
- Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: Possible mechanism of nephroprotection
- (2014) Bidya Dhar Sahu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma
- (2014) Liliane Hobeika et al. BMC Nephrology
- Olmesartan Attenuates Tacrolimus-Induced Biochemical and Ultrastructural Changes in Rat Kidney Tissue
- (2014) Naif O. Al-Harbi et al. Biomed Research International
- Carfilzomib-related acute kidney injury may be prevented by N-acetyl-l-cysteine
- (2014) Rimda Wanchoo et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma
- (2013) M. Wang et al. BLOOD
- U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
- (2013) T. M. Herndon et al. CLINICAL CANCER RESEARCH
- Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
- (2013) D. Siegel et al. HAEMATOLOGICA
- Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
- (2013) A Z Badros et al. LEUKEMIA
- Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)
- (2012) Roman Hájek et al. BMC CANCER
- An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib
- (2012) Ravi Vij et al. BRITISH JOURNAL OF HAEMATOLOGY
- Quercetin Ameliorates Cardiovascular, Hepatic, and Metabolic Changes in Diet-Induced Metabolic Syndrome in Rats
- (2012) Sunil K. Panchal et al. JOURNAL OF NUTRITION
- Role of carfilzomib in the treatment of multiple myeloma
- (2012) Rashid Z Khan et al. Expert Review of Hematology
- Rutin Attenuates Metabolic Changes, Nonalcoholic Steatohepatitis, and Cardiovascular Remodeling in High-Carbohydrate, High-Fat Diet-Fed Rats
- (2011) Sunil K. Panchal et al. JOURNAL OF NUTRITION
- Evaluation for Antioxidant and Renoprotective Activity of Olmesartan Using Nephrectomy Rats
- (2009) Daisuke Kadowaki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity
- (2009) Mohamed A. Ibrahim et al. PHARMACOLOGICAL RESEARCH
- Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats
- (2008) Nagla A. El-Shitany et al. FOOD AND CHEMICAL TOXICOLOGY
- Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
- (2008) O. Benavente-García et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started